足部动脉钙化评分与慢性肢体威胁性缺血患者大截肢风险相关
本研究为单中心回顾性研究,纳入250例因慢性肢体威胁性缺血(CLTI)行腹股沟下血运重建且具备足部X线片的患者,采用0-5分MAC评分评估踝下钙化负荷。结果显示MAC评分越高,大截肢风险显著增加(P<.0001),且独立于WIfI分期和糖尿病等因素。
要点
- MAC评分是简单实用的踝下钙化评估工具,可独立预测CLTI患者大截肢风险。
- MAC评分5分者大截肢风险是0-1分者的4.9倍(HR 4.9,95%CI 1.9-13.1)。
- MAC评分可补充WIfI分期,进一步分层大截肢风险。
核心结论
- MAC评分是CLTI患者大截肢的强独立预测因子,可提供现有CLTI分期系统未测量的临床信息。
研究设计与样本
- 单中心回顾性研究,纳入2011年1月至2019年7月因CLTI行腹股沟下血运重建且有足部X线片的250例患者。
- 由一名盲法评审者根据双位足部X线片计算MAC评分(0-5分)。
主要发现
- MAC评分分布:0分36%,1分5.2%,2分8.4%,3分14%,4分14%,5分21%。
- 中位随访759天(四分位距264-1541天),MAC评分越高与大截肢风险显著相关(P<.0001)。
- 多因素Cox回归中,MAC评分5分vs 0-1分HR 4.9(95%CI 1.9-13.1,P=.001),MAC评分2-4分vs 0-1分HR 3.4(95%CI 1.3-8.8,P=.01),WIfI 4期vs 1-3期HR 2.1(95%CI 1.1-3.9,P=.03)。
- 在WIfI 3-4期(191/250,76%)和糖尿病患者(185/250,74%)亚组中,MAC评分仍可进一步分层大截肢风险。
- 与更高MAC评分独立相关的变量:男性、糖尿病、终末期肾病、GLASS足部分数。
关键数值与推荐
- MAC评分方法:双位足部X线片,足背动脉、跖动脉、跖骨动脉钙化>2cm各计1分,拇趾及非拇趾趾动脉钙化>1cm各计1分,总分0-5分。
- 三分类:轻度(0-1分)、中度(2-4分)、重度(5分)。
临床怎么用
- 可利用足部平片计算MAC评分,辅助WIfI分期识别大截肢高危CLTI患者。
- 对MAC评分高(尤其5分)者,应强化保肢策略和随访。
局限性
- 单中心回顾性设计,样本量250例,结论需外部验证。
- MAC评分由单一盲法评审者计算,未报告评分者间一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The medial arterial calcification (MAC) score is a simple metric that describes the burden of inframalleolar calcification using a plain foot radiograph. We hypothesized that a higher MAC score would be independently associated with the risk of major amputation in patients with chronic limb-threatening ischemia (CLTI). METHODS: We performed a single-institution, retrospective study of 250 patients who had undergone infrainguinal revascularization for CLTI from January 2011 to July 2019 and had foot radiographs available for MAC score calculation. A single blinded reviewer assigned MAC scores of 0 to 5 using two-view minimum plain foot radiographs, with 1 point each for calcification of >2 cm in the dorsalis pedis, plantar, and metatarsal arteries and >1 cm in the hallux and non-hallux digital arteries. RESULTS: The MAC score was 0 in 36%, 1 in 5.2%, 2 in 8.4%, 3 in 14%, 4 in 14%, and 5 in 21%. The MAC score was trichotomized to facilitate analysis and clinical utility (mild, MAC score 0-1; moderate, MAC score 2-4; and severe, MAC score 5). The variables independently associated with a higher MAC score were male sex, diabetes, end-stage renal disease, and the global limb anatomic staging system pedal score. The MAC score was not associated with the Society for Vascular Surgery WIfI (wound, ischemia, foot infection) grade or overall WIfI stage (P = .58). The median follow-up was 759 days (interquartile range, 264-1541 days). A higher MAC score was significantly associated with the risk of major amputation (P < .0001). In a Cox proportional hazards multiple regression model for major amputation that included the trichotomized MAC score, diabetes, end-stage renal disease, and WIfI stage (1-3 vs 4). The MAC score (MAC score 5: hazard ratio [HR], 4.9; 95% confidence interval [CI], 1.9-13.1; P = .001; MAC score 2-4: HR, 3.4; 95% CI, 1.3-8.8; P = .01) and WIfI stage (WIfI stage 4: HR, 2.1; 95% CI, 1.1-3.9; P = .03) were significantly associated with the risk of major amputation. In the subsets of patients with the most advanced WIfI stage of 3 to 4 (191 of 250; 76%) and patients with diabetes (185 of 250; 74%), the MAC score further stratified the risk of major amputation on univariate and multivariate analyses. CONCLUSIONS: The MAC score is a simple, practical tool and a strong independent predictor of major amputation in patients with CLTI. It provides novel clinical data that are currently unmeasured using any validated CLTI staging system. The MAC score is a promising standardized measure of inframalleolar disease burden that can be used in conjunction with the WIfI staging system to help improve outcomes stratification and determine the optimal treatment strategies for patients with CLTI.
引用
- Liu IH, Wu B, Krepkiy V, et al. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia. J Vasc Surg. 2021. PMID: 34481900. doi:10.1016/j.jvs.2021.07.235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。